These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2323803)

  • 1. Nutritional management of portal systemic encephalopathy.
    Nizami F; Qureshi H; Zuberi SJ
    Indian J Gastroenterol; 1990 Apr; 9(2):165-6. PubMed ID: 2323803
    [No Abstract]   [Full Text] [Related]  

  • 2. Portal systemic encephalopathy (PSE).
    Qureshi H; Shahid A; Nizami F; Zuberi SJ
    J Pak Med Assoc; 1987 Feb; 37(2):25-33. PubMed ID: 3106660
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperprolactinemia in portosystemic encephalopathy.
    Sharma MP; Acharya SK; Karmarkar MG
    Indian J Med Res; 1987 Sep; 86():372-4. PubMed ID: 3428971
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood serotonin level and selected aromatic amino acids in the serum, liver tissue and brain of deceased persons with encephalopathy and hepatic coma in viral hepatitis and liver cirrhosis].
    Szpakowicz T; Boroń P; Zimnoch L; Bobrowska E
    Pol Arch Med Wewn; 1988 Jun; 79(6):314-8. PubMed ID: 3271307
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic failure: etiologies, manifestations, and management. Home study program.
    Keith JS
    Crit Care Nurse; 1985; 5(1):59-86. PubMed ID: 3884278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intensive therapy and the outcome of hepatic coma in liver cirrhosis in children].
    Men'kova TN; Deputatova LD; Dikova AA; Lyskova TF; Gorokhov AM
    Vopr Okhr Materin Det; 1978 Aug; 23(8):51-5. PubMed ID: 695406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis].
    Shuliat'ev IS; Il'chenko LIu; Vinnitskaia EV; Petrakov AV; Sil'verstrova SIu
    Eksp Klin Gastroenterol; 2002; (5):38-41, 127. PubMed ID: 12619575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy.
    Greenberger NJ; Carley J; Schenker S; Bettinger I; Stamnes C; Beyer P
    Am J Dig Dis; 1977 Oct; 22(10):845-55. PubMed ID: 335882
    [No Abstract]   [Full Text] [Related]  

  • 9. A non-invasive method for evaluating cirrhotic portal hypertension by administration of 99mTc-MIBI per rectum.
    Wang JY; Chen SL; Chen FZ; Xu WG; Hu DC; Chen XF; Jin G; Liu HY
    J Gastroenterol Hepatol; 1995; 10(2):169-73. PubMed ID: 7787163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary management of hepatic encephalopathy in cirrhotic patients: survey of current practice in United Kingdom.
    Soulsby CT; Morgan MY
    BMJ; 1999 May; 318(7195):1391. PubMed ID: 10334749
    [No Abstract]   [Full Text] [Related]  

  • 11. [Basics of nutrition in cirrhosis of the liver].
    Mörk H
    MMW Fortschr Med; 2007 Apr; 149(17):33-4. PubMed ID: 17674907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An unrecognized phenomenon during the death of cirrhotics: complete portal exclusion of the liver].
    MORETTI GF; STAEFFEN J; BALLAN P
    Presse Med (1893); 1962 Jan; 70():185-7. PubMed ID: 14475927
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
    Chang CC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Chang T; Huang HC; Lee FY; Lee SD
    Eur J Pharmacol; 2017 May; 802():36-43. PubMed ID: 28238769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hepatic encephalopathy.
    Plauth M; Merli M; Kondrup J
    N Engl J Med; 1997 Dec; 337(26):1921-2. PubMed ID: 9417530
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute cerebral edema as part of the syndrome of hepatic encephalopathy in an individual with chronic liver disease: a case report.
    Jabbour N; Karavias D; Van Thiel DH
    J Okla State Med Assoc; 1994 Nov; 87(11):501-3. PubMed ID: 7815183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep).
    Janssen HL; Brouwer JT; Nevens F; Sanchez-Tapias JM; Craxi A; Hadziyannis S
    BMJ; 1993 Jan; 306(6870):107-8. PubMed ID: 8435602
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evolutive characteristics of hepatic cirrhosis as a function of its etiology].
    Buligescu L; Ciontea M; Boca M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):383-8. PubMed ID: 6120555
    [No Abstract]   [Full Text] [Related]  

  • 20. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.
    Riggio O; Efrati C; Catalano C; Pediconi F; Mecarelli O; Accornero N; Nicolao F; Angeloni S; Masini A; Ridola L; Attili AF; Merli M
    Hepatology; 2005 Nov; 42(5):1158-65. PubMed ID: 16250033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.